- Tytuł :
- Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trialResearch in context
- Autorzy :
- Temat :
-
SARS-CoV-2
COVID-19
Recombinant protein vaccine
Nanoparticle vaccine
Immunogenicity
Safety
Medicine (General)
R5-920 - Źródło :
- EClinicalMedicine, Vol 64, Iss , Pp 102140- (2023)
- Opis pliku :
- electronic resource
- Relacje :
- http://www.sciencedirect.com/science/article/pii/S2589537023003176; https://doaj.org/toc/2589-5370
- Dostęp URL :
- https://doaj.org/article/608a2ee1e423411eb689bce93946af34
-
Czasopismo naukowe